IP Library Patent Application 10573610
Patent Application
App. No. 10/573,610

Rho Antibody And Tag To Purify Cell Surface Proteins

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/573,610
Abstract

A process for the expression and purification of membrane associated proteins is provided. A process for the expression and purification of membrane proteins such as G-protein coupled receptors is provided. A hybrid polypeptide is constructed from a protein of interest and a peptide tag from the amino-terminus extracellular domain of rhodopsin. A method for purifying the hybrid protein using the rhodopsin tag is provided. Methods of detecting the expressed hybrid are also provided.

Claims (31)

1 . A hybrid polypeptide comprising:

a target polypeptide,

an identification peptide comprising the amino-terminal extracellular domain of rhodopsin, where said identification peptide is linked to the amino-terminus of said target polypeptide.

2 . The hybrid polypeptide of claim 1 where said identification peptide comprises an amino terminal extracellular domain of bovine rhodopsin.

3 . The hybrid polypeptide of claim 2 where said identification peptide comprises amino-terminal amino acids of bovine rhodopsin selected from the group consisting of: a first 20, a first 25, a first 30, and a first 35 amino acids.

4 . The hybrid polypeptide of claim 1 where said target polypeptide comprises a membrane protein.

5 . The hybrid polypeptide of claim 4 where said target polypeptide comprises a G-protein coupled receptor protein.

6 . A method of purifying a target polypeptide comprising:

expressing a hybrid polypeptide comprising an identification peptide of the amino terminal extracellular domain of rhodopsin fused to the amino terminal region of a target polypeptide,

forming a complex of said hybrid polypeptide with an antibody against said amino terminal domain of rhodopsin,

isolating said complex, and

dissociating said hybrid polypeptide from said antibody.

7 . The method of claim 6 where said target polypeptide comprises a G-protein coupled receptor.

8 . The method of claim 6 where said identification peptide comprises amino-terminal amino acids of bovine rhodopsin selected from the group consisting of: a first 20, a first 25, a first 30, and a first 35 amino acids.

9 . The method of claim 8 where said antibody is directed against a first 15 amino acids of bovine rhodopsin.

10 . The method of claim 6 where said antibody is held by a resin.

11 . The method of claim 6 where said hybrid polypeptide is dissociated from said antibody by a pH gradient

12 . The method of claim 6 where said hybrid polypeptide is dissociated from said antibody by a salt gradient.

13 . The method of claim 6 where said hybrid polypeptide is dissociated from said antibody by competing with a peptide comprising of all or a portion of the amino terminal domain of rhodopsin.

14 . A method of labeling a target polypeptide comprising:

expressing a hybrid polypeptide comprising: an amino terminal extracellular domain of rhodopsin fused to an amino terminal region of a target polypeptide;

forming a complex of said hybrid polypeptide and an antibody against said amino terminal extracellular domain of rhodopsin; and

detecting said complex by means of a reporting agent.

15 . The method of claim 14 where said amino terminal domain of rhodopsin comprises amino-terminal amino acids of bovine rhodopsin selected from the group consisting of: a first 20, a first 25, a first 30, and a first 35 amino acids.

16 . The method of claim 15 where said antibody is directed against a first 15 amino acids of bovine rhodopsin.

17 . The method of claim 14 where said target polypeptide is a G-protein coupled receptor.

18 . The method of claim 14 where said reporting agent is conjugated to said antibody.

19 . The method of claim 14 where said reporting agent is a fluorescent marker.

20 . The method of claim 14 where said reporting agent is an enzymatic marker.

21 . The method of claim 14 where said reporting agent is a radioactive marker.

22 . The method of claim 14 where said complex is detected by biding said complex to a secondary antibody against said antibody to the amino terminal extracellular domain of rhodopsin, and said secondary antibody is linked to a reporting agent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2007
From: MENDEZ, MICHAEL J.; BEHNKE, CRAIG; HOKANSON, CRAIG
To: SAGRES DISCOVERY, INC.
Reel/Frame 019318/0964 →